NCT02238197View on ClinicalTrials.gov

Postmarketing Surveillance Study of Atrovent® Inhalation Solution in Chronic Obstructive Pulmonary Disease

CompletedOBSERVATIONAL
Enrollment

477

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

October 31, 2001

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Atrovent® Inhalation Solution

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY